Joseph S. Zakrzewski
Director · AN2 Therapeutics, Inc.
IndividualBuying only
- 2024
- Aug 14, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Joseph S. Zakrzewski files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robin Shane Readnour - $317K in ANTX purchases and sales in the last 12 months
- Joshua M. Eizen - $53K in ANTX purchases and sales in the last 12 months
- Margaret M. Fitzpatrick - $12K in ANTX purchases and sales in the last 12 months
- Sanjay Chanda - $9K in ANTX purchases and sales in the last 12 months
- Lucy Day - $9K in ANTX purchases and sales in the last 12 months
- Stephen David Prior - $7K in ANTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joseph S. Zakrzewski?
Joseph S. Zakrzewski is a corporate insider, tracked as Director of AN2 Therapeutics, Inc. (ANTX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Joseph S. Zakrzewski submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Joseph S. Zakrzewski been buying or selling stock?
Recorded transactions: 3 open-market purchases ($28K) and 0 open-market sales across all tracked filings.
